Tagresults

Uresta, a Canadian femtech startup that develops non-invasive solution for bladder leaks, has officially launched in the U.S.

naturalX Health Ventures (naturalX), a venture capital fund, has secured €100 million fund to accelerate the future of consumer health in Europe

REEV, a pioneering medical technology startup developing intelligent, lightweight wearable robotics, announced $9.2 million funding round

The National Kidney Foundation (NKF) Innovation Fund has invested in Canadian startup Northernmost, to advance its next-generation kidney preservation technology.

Diag-Nose.io has closed oversubscribed $2 million round seed round to transform the management of chronic respiratory diseases with AI.

Nintx (Next Innovative Therapeutics), a biotech startup researching and developing treatments for multifactorial diseases using Brazil’s biodiversity, has raised additional $10 million funding.

Revisto, a pioneering AI-powered solution streamlining the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials, has secured $4 million in seed funding.

PicnicHealth, a healthtech startup dedicated to simplifying healthcare for everyone, has unveiled an AI assistant that empowers patients to take control of their healthcare.

Definition Health, a UK-based, clinician-led healthtech innovator, has secured £5.75 million in pre-seed funding for surgical care with cutting-edge predictive AI.

Brand Engagement Network (BEN), a global player in secure and reliable conversational AI solutions for businesses and consumers, has agreed to acquire 100% of Cataneo, a privately-owned media technology company based in Munich, in a cash and stock transaction.

Aignostics, a Berlin-based AI startup that turns complex multi-modal pathology data into transformative insights, announced it has raised $34 million in Series B financing.

HeartX, powered by HealthTech Arkansas and MedAxiom - along with numerous cardiology practices in Arkansas and around the country - has selected four healthcare startups to participate in its 2024 accelerator program.

Frankfurt-based startup Qualifyze, a trusted company in supplier risk management in the life sciences industry, announced $54 million in Series B funding from global software investor Insight Partners, with participation from existing investors HV Capital, HarbourVest Partners, H14 and Cherry Ventures.

Sonio, the medtech company specializing in women’s and children’s health, announced the official approval by the French Ministry of the Economy and Finance of the acquisition of 100% of shares by Samsung Medison, a Korean manufacturer of diagnostic ultrasound systems.

Terumo Corporation (Terumo), a global pioneer in medical technology, has established Terumo Ventures, a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, as a department within Terumo Americas Holding.

The European Investment Bank (EIB), is providing €20 million in venture-debt financing to German medical-technology company Protembis to develop a next-generation device for protecting the brains of patients who undergo certain heart treatments.

INVI MindHealth, a pioneering mental health technology startup, announced the close of $1.5 million series seed funding round.

Formation Bio, a tech-driven and AI-native pharma company, has raised $372 million Series D financing. The financing was led by a16z with significant participation from Sanofi. Current investors also joined the round, including Sequoia, Thrive, Emerson Collective, and Lachy Groom, along with new investors, such as SV Angel Growth and FPV Ventures.

SCI Ventures, a new venture philanthropy vehicle dedicated to funding and commercializing innovative treatments for spinal cord injury, has announced the launch of its first fund.

2Flo Ventures, an emerging venture capital firm and startup studio focused on the discovery, development and commercialization of healthcare solutions that address disparities in outcomes and health equity broadly, has announced the appointment of Charlotte Jones-Burton as a Partner and Head of Life Science Product Development and Strategy.